Pfizer and Flagship Pioneering, ... The Pfizer logo is pictured on their headquarters building in the Manhattan borough of New York City, New York, U.S., Nov. 9, ...

Cambridge venture firm Flagship Pioneering's latest startup is starting very small: by looking for mutations at the cellular level to find, then target, genetic causes of disease.

ProFound logo. Pioneering Medicines, Flagship's in house drug discovery and development unit, is responsible for leading the partnership with Pfizer, including driving the exploration process to ...

Launched in 2000, Flagship focuses on inventing and building bioplatform companies. Since its inception, the company has launched more than 100 ventures, amassing an aggregate value of $75bn.

Flagship Pioneering is unveiling a new startup that takes aim at tricky-to-drug bodily targets by creating an "address map" of the human body. Former Rubius CEO jumps to another Flagship spinout ...

Noubar Afeyan, Flagship Pioneering CEO and Moderna co-founder speaks at MIT in May. Flagship announced it raised another $3.6 billion to identify promising technologies and build companies around ...

Flagship Pioneering is backing the startup with $50 million. By Frank Vinluan on May 16, 2023 1:31 pm. Share. Share ... Metaphore has been quietly developing its technology within Flagship Labs, ...

GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines Respiratory disease and immunology are the initial focus areas of GSK’s new drug discovery partnership with ...

Flagship Pioneering, the venture capital firm behind Moderna, unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Flagship, which has incubated biotech companies, most famously Moderna Inc , and Pfizer will each invest $50 million. Flagship's drug discovery initiative Pioneering Medicines will lead the ...